Audio Interview: New Research on Possible Treatments for Covid-19.
Identifieur interne : 000B38 ( PubMed/Checkpoint ); précédent : 000B37; suivant : 000B39Audio Interview: New Research on Possible Treatments for Covid-19.
Auteurs : Eric J. Rubin ; Lindsey R. Baden ; Stephen MorrisseySource :
- The New England journal of medicine [ 1533-4406 ] ; 2020.
Descripteurs français
- KwdFr :
- Anti-inflammatoires non stéroïdiens (usage thérapeutique), Antiviraux (usage thérapeutique), Association médicamenteuse, Diagnostic différentiel, Essais cliniques comme sujet, Grippe humaine (diagnostic), Hormones corticosurrénaliennes (usage thérapeutique), Humains, Hydroxychloroquine (usage thérapeutique), Infection croisée (), Infections à coronavirus (), Infections à coronavirus (diagnostic), Infections à coronavirus (traitement médicamenteux), Lopinavir (usage thérapeutique), Lutte contre l'infection (), Ritonavir (usage thérapeutique), Récepteurs viraux (antagonistes et inhibiteurs), Soins aux patients, Ventilation artificielle (effets indésirables).
- MESH :
- antagonistes et inhibiteurs : Récepteurs viraux.
- diagnostic : Grippe humaine, Infections à coronavirus.
- effets indésirables : Ventilation artificielle.
- traitement médicamenteux : Infections à coronavirus.
- usage thérapeutique : Anti-inflammatoires non stéroïdiens, Antiviraux, Hormones corticosurrénaliennes, Hydroxychloroquine, Lopinavir, Ritonavir.
- Association médicamenteuse, Diagnostic différentiel, Essais cliniques comme sujet, Humains, Infection croisée, Infections à coronavirus, Lutte contre l'infection, Soins aux patients.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (therapeutic use), Anti-Inflammatory Agents, Non-Steroidal (therapeutic use), Antiviral Agents (therapeutic use), Betacoronavirus, Clinical Trials as Topic, Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Cross Infection (prevention & control), Diagnosis, Differential, Drug Combinations, Humans, Hydroxychloroquine (therapeutic use), Infection Control (methods), Influenza, Human (diagnosis), Lopinavir (therapeutic use), Patient Care, Receptors, Virus (antagonists & inhibitors), Respiration, Artificial (adverse effects), Ritonavir (therapeutic use).
- MESH :
- chemical , antagonists & inhibitors : Receptors, Virus.
- chemical , therapeutic use : Adrenal Cortex Hormones, Anti-Inflammatory Agents, Non-Steroidal, Antiviral Agents, Hydroxychloroquine, Lopinavir, Ritonavir.
- adverse effects : Respiration, Artificial.
- diagnosis : Coronavirus Infections, Influenza, Human.
- drug therapy : Coronavirus Infections.
- methods : Infection Control.
- prevention & control : Coronavirus Infections, Cross Infection.
- therapy : Coronavirus Infections.
- Betacoronavirus, Clinical Trials as Topic, Diagnosis, Differential, Drug Combinations, Humans, Patient Care.
DOI: 10.1056/NEJMe2005759
PubMed: 32187489
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32187489Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Audio Interview: New Research on Possible Treatments for Covid-19.</title><author><name sortKey="Rubin, Eric J" sort="Rubin, Eric J" uniqKey="Rubin E" first="Eric J" last="Rubin">Eric J. Rubin</name></author><author><name sortKey="Baden, Lindsey R" sort="Baden, Lindsey R" uniqKey="Baden L" first="Lindsey R" last="Baden">Lindsey R. Baden</name></author><author><name sortKey="Morrissey, Stephen" sort="Morrissey, Stephen" uniqKey="Morrissey S" first="Stephen" last="Morrissey">Stephen Morrissey</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32187489</idno><idno type="pmid">32187489</idno><idno type="doi">10.1056/NEJMe2005759</idno><idno type="wicri:Area/PubMed/Corpus">000338</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000338</idno><idno type="wicri:Area/PubMed/Curation">000338</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000338</idno><idno type="wicri:Area/PubMed/Checkpoint">000B38</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B38</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Audio Interview: New Research on Possible Treatments for Covid-19.</title><author><name sortKey="Rubin, Eric J" sort="Rubin, Eric J" uniqKey="Rubin E" first="Eric J" last="Rubin">Eric J. Rubin</name></author><author><name sortKey="Baden, Lindsey R" sort="Baden, Lindsey R" uniqKey="Baden L" first="Lindsey R" last="Baden">Lindsey R. Baden</name></author><author><name sortKey="Morrissey, Stephen" sort="Morrissey, Stephen" uniqKey="Morrissey S" first="Stephen" last="Morrissey">Stephen Morrissey</name></author></analytic><series><title level="j">The New England journal of medicine</title><idno type="eISSN">1533-4406</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (therapeutic use)</term><term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term><term>Antiviral Agents (therapeutic use)</term><term>Betacoronavirus</term><term>Clinical Trials as Topic</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (therapy)</term><term>Cross Infection (prevention & control)</term><term>Diagnosis, Differential</term><term>Drug Combinations</term><term>Humans</term><term>Hydroxychloroquine (therapeutic use)</term><term>Infection Control (methods)</term><term>Influenza, Human (diagnosis)</term><term>Lopinavir (therapeutic use)</term><term>Patient Care</term><term>Receptors, Virus (antagonists & inhibitors)</term><term>Respiration, Artificial (adverse effects)</term><term>Ritonavir (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens (usage thérapeutique)</term><term>Antiviraux (usage thérapeutique)</term><term>Association médicamenteuse</term><term>Diagnostic différentiel</term><term>Essais cliniques comme sujet</term><term>Grippe humaine (diagnostic)</term><term>Hormones corticosurrénaliennes (usage thérapeutique)</term><term>Humains</term><term>Hydroxychloroquine (usage thérapeutique)</term><term>Infection croisée ()</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Lopinavir (usage thérapeutique)</term><term>Lutte contre l'infection ()</term><term>Ritonavir (usage thérapeutique)</term><term>Récepteurs viraux (antagonistes et inhibiteurs)</term><term>Soins aux patients</term><term>Ventilation artificielle (effets indésirables)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Receptors, Virus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Anti-Inflammatory Agents, Non-Steroidal</term><term>Antiviral Agents</term><term>Hydroxychloroquine</term><term>Lopinavir</term><term>Ritonavir</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Respiration, Artificial</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Récepteurs viraux</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Ventilation artificielle</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Infection Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Cross Infection</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens</term><term>Antiviraux</term><term>Hormones corticosurrénaliennes</term><term>Hydroxychloroquine</term><term>Lopinavir</term><term>Ritonavir</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Clinical Trials as Topic</term><term>Diagnosis, Differential</term><term>Drug Combinations</term><term>Humans</term><term>Patient Care</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association médicamenteuse</term><term>Diagnostic différentiel</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Infection croisée</term><term>Infections à coronavirus</term><term>Lutte contre l'infection</term><term>Soins aux patients</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32187489</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>03</Month><Day>19</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation></Journal><ArticleTitle>Audio Interview: New Research on Possible Treatments for Covid-19.</ArticleTitle><Pagination><MedlinePgn>e30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMe2005759</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rubin</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Baden</LastName><ForeName>Lindsey R</ForeName><Initials>LR</Initials></Author><Author ValidYN="Y"><LastName>Morrissey</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>2494G1JF75</RegistryNumber><NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>O3J8G9O825</RegistryNumber><NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005791" MajorTopicYN="Y">Patient Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32187489</ArticleId><ArticleId IdType="doi">10.1056/NEJMe2005759</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Baden, Lindsey R" sort="Baden, Lindsey R" uniqKey="Baden L" first="Lindsey R" last="Baden">Lindsey R. Baden</name><name sortKey="Morrissey, Stephen" sort="Morrissey, Stephen" uniqKey="Morrissey S" first="Stephen" last="Morrissey">Stephen Morrissey</name><name sortKey="Rubin, Eric J" sort="Rubin, Eric J" uniqKey="Rubin E" first="Eric J" last="Rubin">Eric J. Rubin</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B38 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000B38 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32187489
|texte= Audio Interview: New Research on Possible Treatments for Covid-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32187489" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |